// App-Quantinova.ai

186 : Effects of an established drug on smad signalling pathway in the rat model of monocrotaline pulmonary hypertension

Researchers

Presenter

  • Khaled Habas

Principal Investigators

  • Özlem Eklioğlu

  • Talat Nasim

Medical Centers

  • Anadolu University Faculty of Pharmacy Department of Pharmaceutical Toxicology Eskisehir/Turkey

  • University of Bradford, Bradford, UK

Locations

  • Turkey

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Bone Morphogenetic Protein Receptor Type 2

Drug/Treatment

  • Monocrotaline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved